Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials
Related Posts
Thorp M, Balakasi K, van Oosterhout JJ, Ramesh M, Robson I, Choko A, Shoptaw S, Hoffman R, Cornell M, Dovel K. High-Risk Mobility and Interruption[...]
Heerspink HJL, Neuen BL, Agarwal R, Cherney DZI, Lam CSP, Tuttle KR, Wanner C, Sarafidis P, Chertow GM, Friede T, Barratt J, Floege J, Chew-Wong[...]
Song J, Daniel M, Ardehali A. Not Yet a Nail in the Coffin for Ex Vivo Heart Perfusion. Ann Thorac Surg. 2026 Nov 15:S0003-4975(26)01175-6. doi:[...]